Reuters: Grifols sees core earnings rising by a quarter as it prioritises profitability
BARCELONA, Feb 26 (Reuters) - Healthcare company Grifols (GRLS.MC), opens new tab on Thursday said it expects core earnings to grow by more than a quarter in 2026 and will continue to cut debt.
Grifols sees core earnings rising by a quarter as it prioritises profitability
Seeking Alpha: Grifols: Solid Q3 Execution, But Cash Conversion And 2026 Risks Keep Us Neutral
Grifols: Solid Q3 Execution, But Cash Conversion And 2026 Risks Keep Us Neutral
Seeking Alpha: Grifols: Looking At The Longer-Term 2025-2027 Upside After No Sale
It's time for an update on the Medical company Grifols, S.A. (GRFS). It's been about 4 months since I last updated on the business, with that update being specific to an event where Brookfield Asset ...
Yahoo Finance UK: Assessing Grifols (BME:GRF) Valuation After Recent Share Price Weakness And Perceived Discount
Recent performance context for Grifols Grifols (BME:GRF) has drawn investor attention after a mixed run, with a modest 1 day gain, a negative move over the past week and month, and a deeper decline ...
Assessing Grifols (BME:GRF) Valuation After Recent Share Price Weakness And Perceived Discount
The Globe and Mail: Grifols Refinances 2027 Debt and Extends Maturities with Multi-Billion Term Loan B Package
Detailed price information for Grifols S.A. ADR (GRFS-Q) from The Globe and Mail including charting and trades.
Grifols Refinances 2027 Debt and Extends Maturities with Multi-Billion Term Loan B Package
Spanish plasma-derived medicines company Grifols announced that it has successfully completed the refinancing of its 2027 debt maturities through a new credit agreement structured as a Term Loan B ...